Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Rejuve.Bio Launches Groundbreaking Crowd Fund on NetCapital to Pioneer the Future of Artificial General Intelligence and Longevity | ||
By: PR Newswire Association LLC. - 12 Mar 2024 | Back to overview list |
|
Embark on a journey to redefine aging with cutting-edge biotech innovation. LOS ANGELES, March 12, 2024 /PRNewswire/ -- Rejuve.Bio, a leading AI biotechnology firm at the forefront of the longevity revolution, announces its latest initiative: a Crowd Fundraise on the NetCapital platform. This pivotal move opens a gateway for investors to be part of a transformative journey, leveraging artificial intelligence and genetics to challenge the conventional notions of aging and human healthspan. [See https://netcapital.com/companies/rejuvebiotech for more information.] Focused on harnessing the power of artificial intelligence (AI) and genetics, Rejuve.Bio aims to revolutionize the healthcare and biotech industries by extending human healthspan and redefining the aging process. "Our mission at Rejuve.Bio is not just about extending life but enhancing the quality of life," said Kennedy Schaal, Executive Director at Rejuve.Bio. "With our innovative approach combining AI, genetics, and comprehensive data analysis, we're not just imagining a future where aging is a challenge to be overcome; we're creating it." Highlights of the announcement include:
Why Invest in Rejuve.Bio:
As Rejuve.Bio embarks on this exciting phase, the company invites investors and the public to learn more about this unique opportunity by visiting the NetCapital platform. Go to https://netcapital.com/companies/rejuvebiotech DISCLAIMER: This release is meant for informational purposes only, and is not intended to serve as a recommendation to buy or sell any security in a self-directed account and is not an offer or sale of a security. Any investment is not directly managed by Rejuve.Bio. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Potential investors should seek professional advice and carefully review all documentation before making any investment decisions. About Rejuve Bio Contact: Lewis Farrell
Logo - https://mma.prnewswire.com/media/2360612/Rejuve_Bio_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/rejuvebio-launches-groundbreaking-crowd-fund-on-netcapital-to-pioneer-the-future-of-artificial-general-intelligence-and-longevity-302087003.html SOURCE Rejuve Bio |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |